Cost-Effective Screening for Trichomoniasis

por Schwebke, Jane R.
Publicado 2002

Accuracy of Self-Report of Sexual Activity among Adolescent Girls: Implications for Interpretation of Vaginal Flora Patterns

por Muzny, Christina A., Schwebke, Jane R.
Publicado 2015

Pilot Study to Evaluate the Appropriate Management of Patients With Coexistent Bacterial Vaginosis and Cervicitis

por Schwebke, Jane R., Schulien, Mary Beth, Zajackowski, Mark
Publicado 1995

A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vagino...

por Schwebke, Jane R., Marrazzo, Jeanne, Beelen, Andrew P., Sobel, Jack D.
Publicado 2015

Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis

por Schwebke, Jane R., Gaydos, Charlotte A., Nyirjesy, Paul, Paradis, Sonia, Kodsi, Salma, Cooper, Charles K.
Publicado 2018

Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis

por Nyirjesy, Paul, Schwebke, Jane R, Angulo, David A, Harriott, Itzel A, Azie, Nkechi E, Sobel, Jack D
Publicado 2021

Characterization of the Vaginal Microbiota among Sexual Risk Behavior Groups of Women with Bacterial Vaginosis

por Muzny, Christina A., Sunesara, Imran R., Kumar, Ranjit, Mena, Leandro A., Griswold, Michael E., Martin, David H., Lefkowitz, Elliot J., Schwebke, Jane R.
Publicado 2013

Correction: Characterization of the Vaginal Microbiota among Sexual Risk Behavior Groups of Women with Bacterial Vaginosis

por Muzny, Christina A., Sunesara, Imran R., Kumar, Ranjit, Mena, Leandro A., Griswold, Michael E., Martin, David H., Lefkowitz, Elliot J., Schwebke, Jane R.
Publicado 2013

A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis

por Waldbaum, Arthur S., Schwebke, Jane R., Paull, Jeremy R. A., Price, Clare F., Edmondson, Stephanie R., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R.
Publicado 2020

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

por Schwebke, Jane R., Carter, Belvia A., Waldbaum, Arthur S., Agnew, Kathy J., Paull, Jeremy R.A., Price, Clare F., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R.
Publicado 2021

Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis

por Ravel, Jacques, Brotman, Rebecca M, Gajer, Pawel, Ma, Bing, Nandy, Melissa, Fadrosh, Douglas W, Sakamoto, Joyce, Koenig, Sara SK, Fu, Li, Zhou, Xia, Hickey, Roxana J, Schwebke, Jane R, Forney, Larry J
Publicado 2013

Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010

por Kirkcaldy, Robert D., Augostini, Peter, Asbel, Lenore E., Bernstein, Kyle T., Kerani, Roxanne P., Mettenbrink, Christie J., Pathela, Preeti, Schwebke, Jane R., Secor, W. Evan, Workowski, Kimberly A., Davis, Darlene, Braxton, Jim, Weinstock, Hillard S.
Publicado 2012

Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study

por Schwebke, Jane R., Taylor, Stephanie N., Ackerman, Ronald, Schlaberg, Robert, Quigley, Neil B., Gaydos, Charlotte A., Chavoustie, Steven E., Nyirjesy, Paul, Remillard, Carmelle V., Estes, Philip, McKinney, Byron, Getman, Damon K., Clark, Craig
Publicado 2020

Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women

por Schwebke, Jane R., Gaydos, C. A., Davis, T., Marrazzo, J., Furgerson, D., Taylor, S. N., Smith, B., Bachmann, L. H., Ackerman, R., Spurrell, T., Ferris, D., Burnham, C.-A. D., Reno, H., Lebed, J., Eisenberg, D., Kerndt, P., Philip, S., Jordan, J., Quigley, N.
Publicado 2018

Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study

por Muzny, Christina A, Schwebke, Jane R, Nyirjesy, Paul, Kaufman, Gregory, Mena, Leandro A, Lazenby, Gweneth B, Van Gerwen, Olivia T, Graves, Keonte J, Arbuckle, Janeen, Carter, Belvia A, McMahon, Connette P, Eder, Scott, Shaw, Jackie, Pandey, Brajesh, Chavoustie, Steven E
Publicado 2021

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

por Schwebke, Jane R, Sobel, Ryan, Gersten, Janet K, Sussman, Steven A, Lederman, Samuel N, Jacobs, Mark A, Chappell, B Todd, Weinstein, David L, Moffett, Alfred H, Azie, Nkechi E, Angulo, David A, Harriott, Itzel A, Borroto-Esoda, Katyna, Ghannoum, Mahmoud A, Nyirjesy, Paul, Sobel, Jack D
Publicado 2021